Cargando…

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection

Background: Previously reported transcriptional signatures for predicting the prognosis of stage I-III bladder cancer (BLCA) patients after surgical resection are commonly based on risk scores summarized from quantitative measurements of gene expression levels, which are highly sensitive to the meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yawei, Zhang, Huarong, Guo, You, Cai, Hao, Li, Xiangyu, He, Jun, Lai, Hung-Ming, Guan, Qingzhou, Wang, Xianlong, Guo, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635465/ https://www.ncbi.nlm.nih.gov/pubmed/31355144 http://dx.doi.org/10.3389/fonc.2019.00629

Ejemplares similares

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
por: He, Jun, et al.
Publicado: (2019)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings
por: Liu, Huaping, et al.
Publicado: (2017)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022)

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
por: Gao, Fei, et al.
Publicado: (2020)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
por: Liu, Yixin, et al.
Publicado: (2019)

The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome
por: Guan, Qingzhou, et al.
Publicado: (2020)

Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
por: Sun, Jian-Xuan, et al.
Publicado: (2023)

Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings
por: Cai, Hao, et al.
Publicado: (2018)

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
por: Yan, Haidan, et al.
Publicado: (2019)

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study
por: Lu, Jun, et al.
Publicado: (2020)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)

Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer
por: Xu, Xiaopan, et al.
Publicado: (2021)

A rank-based algorithm of differential expression analysis for small cell line data with statistical control
por: Li, Xiangyu, et al.
Publicado: (2017)

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes
por: Cai, Hao, et al.
Publicado: (2019)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Risk Stratification for the Rate and Location of Residual Bladder Tumor for the Decision of Re-Transurethral Resection of Bladder Tumor
por: Fan, Junjie, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021)

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients
por: Guo, Meiying, et al.
Publicado: (2020)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
por: Guan, Qingzhou, et al.
Publicado: (2021)

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Tumor Stage-Based Gross Tumor Volume of Resectable Esophageal Squamous Cell Carcinoma Measured on CT: Association With Early Recurrence After Esophagectomy
por: Wu, Yu-ping, et al.
Publicado: (2021)

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
por: Homan, Morgan, et al.
Publicado: (2022)

Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC
por: Jin, Long, et al.
Publicado: (2023)

Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
por: Tang, Xiaohuan, et al.
Publicado: (2022)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

A novel prognostic model based on three integrin subunit genes-related signature for bladder cancer
por: Tu, Hongtao, et al.
Publicado: (2022)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Gu, Yi-Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jo5f1dshqpdm6ac59jvgn1k35g